The CRS is associated with the binding of IFX to the transmembrane TNF alpha in immune cells that activates a cascade of apoptotic signalling which is observed within few hours from the administration with cell degradation and massive release of cytokines in Rheumatoid Arthritis (RA) and CD patients [8, 21]. The gene discussed is TNF; the disease is rheumatoid arthritis.